why choose us

First received: June 21, 2023

Clinical Trial: Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Presbyopia

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Eye Diseases

Study Type: INTERVENTIONAL


Official Title: A Prospective, Single-Center, Open-Label, Study of the Plasma Pharmacokinetics and Safety Following Topical Administration of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With Pres

Brief Summary: This is a single-center, open-label, randomized study to assess the plasma pharmacokinetic profile of LNZ101 and LNZ100.

Read more